Arterex

Executive Summary

Arterex is a global medical device contract manufacturing organization (CMO) headquartered in Irvine, California, founded in 2015. The company offers vertically integrated design, development, and manufacturing services, including injection molding, extrusion, metals processing, and assembly, serving leading companies across cardiovascular, diagnostics, drug delivery, and surgical technologies. By accelerating innovation from concept to commercialization, Arterex positions itself as a key partner for medtech firms seeking to reduce time-to-market and optimize supply chains. With a focus on quality and scalability, the company caters to the growing trend of outsourcing among medical device OEMs, which seek to leverage specialized expertise and capacity. Arterex's competitive advantages lie in its integrated capabilities and expertise across multiple therapeutic areas, enabling it to handle complex projects and regulatory requirements. The company is well-positioned to benefit from the increasing demand for minimally invasive devices and the expansion of the cardiovascular market. However, as a private CMO, its growth is closely tied to client wins, capacity investments, and industry trends. The outlook remains positive, driven by the broader medical device outsourcing market expected to grow at a steady pace. Key risks include concentration of clients, pricing pressures, and supply chain disruptions. Overall, Arterex demonstrates a solid foundation for sustained growth, though visibility into near-term performance is limited due to its private status.

Upcoming Catalysts (preview)

• Q3 2026New Manufacturing Facility or Capacity Expansion70% success
• Q4 2026Major Client Contract Win with a Top Medtech Company50% success
• 2026Industry Tailwind from Increased Outsourcing by Cardiovascular Device Firms65% success